Navigation Links
UTC Power Acquires Dome-Tech Group
Date:10/1/2007

mbining Dome-Tech with UTC Power. Our shared vision will provide our clients with technical as well as financial solutions for energy cost reduction. Together we will transform energy conservation into the next alternative energy source. Energy conservation still remains the single, most cost-effective method for reducing carbon footprint and energy costs."

United Technologies Corp., based in Hartford, Conn., provides high-technology products and services to the building and aerospace industries. Its UTC Power unit in South Windsor, Conn., is a full-service provider of environmentally advanced power solutions. UTC Power is a world leader with nearly 50 years experience in developing and producing fuel cells for on-site power, transportation, space and defense applications, as well as a leader in innovative renewable energy solutions and combined cooling, heating and power solutions for the distributed energy market.

Contact: Peg Hashem

(860) 727 2093

Peg.hashem@utcpower.com


'/>"/>
SOURCE UTC Power
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Antibiotics losing their power against acne
2. Chewing gum found to increase brainpower
3. New genital gel could empower women against the AIDS epidemic
4. Some languages require more brain power
5. Exercising To Music Found To Boost Brain Power
6. Stretching May Not Decrease Risk Of Injury In Power Sports
7. Zinc increases thinking power of children
8. Childhood leukemia linked to residence close to high voltage power lines
9. Warning Signs On Powered Baby Milk
10. Testing Your Health & Charging Your Mobile At One Go - Check Out The Urine Powered Batteries
11. Implantable devices to be powered by organosilicon compounds in the future
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...oducts, home to sodium, study says , , ...lenty of sodium -- commonly known as salt -- in fo...should know that lower-fat foods can have much mor...inding of a report published online Monday by Con... 37 common supermarket items and found large amoun...
(Date:12/2/2008)...eld biopharmaceutical company, today announced tha...nvestigational product candidate, HZT 501, met all... fixed-dose combination product containing ibuprof...gnificant reduction in the incidence of non-steroi...astrointestinal (gastric and/or duodenal) ulcers i...
(Date:12/2/2008)...roPhage, Inc., http://www.microphage.com , annou...e company,s Board of Directors. Taussig was presi...rch Center in Denver, the nation,s leading institu... to 2006. His medical specialty,is pediatric pul...ensively and am impressed with its progress,in de...
(Date:12/2/2008)...-- In the wake of the deaths of two persons in pub...ern of abuse and neglect of those who have psychia...ndividuals is calling on the incoming Obama admini...als to institute widespread, substantive reforms i...would include raising standards and regulatory exp...
Breaking Medicine News(10 mins):Health News:High Salt Levels Common in Many Foods 2Health News:Horizon Therapeutics announces 2 pivotal HZT-501 Phase 3 trials meet primary endpoints 2Health News:MicroPhage Selects Lynn Taussig, MD for Board of Directors 2Health News:Tragedies Underscore Crisis in U.S. Public Mental Health System: National Advocacy Organization Demands Reforms 2Health News:Tragedies Underscore Crisis in U.S. Public Mental Health System: National Advocacy Organization Demands Reforms 3
...ngh set up a task force to fill up the healthcare ... lab technicians. The recruitment not only fills /...unemployed. The move is based on the recommendati...onal Commission on Macroeconomics and Health, high...
...d the lives of two children in Mumbai and many mor...ed at various hospitals. // Health authorities sai...to treat those 90-odd people who are undergoing tr... to hospitals Wednesday, particularly in south Mum...
...proved that decrease in the fine particulate air p...pulation. This drop in mortality rates was specifi...ory disease, according to Dr. Francine Laden, from...lained in a statement. Several epidemiologic studi...
...higher in the opinion of parents’ when compared to...as new research has pointed out that Australian Fo...ed to all other types of football. // The Aussie ...ports injuries, the second place being occupied by...
Other Medicine News:
(Date:11/26/2008)...., Nov. 26 Children who...gnificantly increased risk of developing mental il... a Mayo Clinic study published this month in Pedi...emy of Pediatrics. , , The retrospective st...ith strabismus (misaligned eyes) and compared them...
(Date:11/25/2008)...ss can improve recovery , , Audio and Web V...le on the Mayo Clinic News Blog. Please see the bo...ROCHESTER, Minn., Nov. 25 /PRNewswire-USNewswire/ ...patients don,t think they,re having a stroke -- an...ir condition worsens. The findings appear in the c...
(Date:11/25/2008)...ISCO, Calif., Nov. 25 Proteolix, I... novel therapeutics that target,protein degradati...ay,announced that data from two ongoing Phase 2 c... will be presented at the upcoming 50th Annual Mee... Carfilzomib is the first in a new class,of spec...
(Date:11/25/2008)...rolled in Clinical Trial to Assess Survival of Pat...pies for Unresectable Hepatocellular Carcinoma , ...ight Sciences Oncology, Inc. (LSO) today announced...clinical trial of Light Infusion Therapy(TM) (Litx...ar carcinoma (HCC), also known as hepatoma or prim...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Micromet Added to NASDAQ Biotechnology Index 9384 1Micromet Added to NASDAQ Biotechnology Index 9384 2Micromet Added to NASDAQ Biotechnology Index 9384 3Micromet Added to NASDAQ Biotechnology Index 9384 4Fat Sensing Hormones Might Fight Obesity 30710 1Fat Sensing Hormones Might Fight Obesity 30710 2International workshop aims to boost public engagement work in developing countries 30707 1International workshop aims to boost public engagement work in developing countries 30707 2International workshop aims to boost public engagement work in developing countries 30707 3Rong Li Lab offers insight into adaptive ability of cells 6066 1Rong Li Lab offers insight into adaptive ability of cells 6066 2
...SBOURG, France and VANCOUVER, April 26, 2007,/PRNe.... , a global,specialty pharmaceutical and medical ...rom its European pivotal trial examining the,Vascu...ap(TM)"),will be presented today at a scientific f...fety and efficacy of the Vascular,Wrap(TM) for use...
...very promises to make retina, spinal cord and othe...TON, April 26, 2007 /PRNewswire/ -- Scientists at ...of Harvard Medical,School, have identified a key m...o the adult central nervous system. The,study foun... by,stem cells) has the ability to break down barr...
Other Medicine Technology:Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 2Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 3Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 4Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 5Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 6Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 7Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 2Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 3
...clear, all-silicone Foley catheters eliminate pati... designs. As an inert, toxin-free elastomer, silic... catheter. Unlike silicone-coated latex Foleys, Ro...leach chemicals or water-soluble proteins that can...
Used for stone manipulation and removal in the urinary tract. Enhanced wire strength permits the basket to expand the ureter more readily than standard flat-wire designs. The Unidex handle facilitate
Used for stone manipulation and removal in the urinary tract. Enhanced wire strength permits greater radial dilation in the ureter. The Unidex handle facilitates easy, ergonomic one-handed operation.
Used to establish and maintain nephrostomy drainage following pyeloplasty. The open ureteral segment promotes patency and allows the stent to adjust as edema subsides. Supplied sterile in peel-open p
Medicine Products: